Results 11 to 20 of about 6,114 (217)
Pseudomonas MitraClip® endocarditis: A case report and review of literature
IDCases, 2020 Endocarditis from Pseudomonas aeruginosa is a rare cause of endocarditis with most of those cases in patients with intravenous drug abuse. The MitraClip® is a relatively new device with few incidences of endocarditis in the literature.
Ralph Tayyar +4 more
doaj +2 more sources
MitraClip device for patients with functional mitral valve regurgitation: A systematic review
Hellenic Journal of Cardiology, 2019 Background: MitraClip device is a novel therapeutic option for patients with degenerative mitral valve regurgitation. Nevertheless, several studies have also focused on the safety and efficacy of this method in functional mitral valve regurgitation (FMR).
Konstantinos T. Chatzistergiou +5 more
doaj +2 more sources
Value of MitraClip in Reducing Functional Mitral Regurgitation [PDF]
US Cardiology Review, 2019 Patients with heart failure who have secondary severe mitral regurgitation due to left ventricular dysfunction have a poor prognosis, with high rates of rehospitalization and mortality.
Mehmet Ali Elbey +2 more
doaj +2 more sources
Cirugía Cardiovascular, 2017 Introducción: La insuficiencia mitral sintomática tiene pronóstico desfavorable sin tratamiento quirúrgico. Esto lleva al desarrollo de técnicas menos invasivas para pacientes no candidatos a cirugía.
Isabel Pernía-Oreña +13 more
doaj +2 more sources
MitraClip implantation under sedation
Revista Portuguesa de Cardiologia, 2018 The percutaneous MitraClip system is a catheter-based device designed to perform edge-to-edge mitral valve (MV) leaflet repair at the site of regurgitation.
Inês Delgado +5 more
doaj +3 more sources
Successful Percutaneous Retrieval of an Embolized MitraClip From the Right Subclavian Artery. [PDF]
Catheter Cardiovasc IntervABSTRACT Single leaflet device attachment (SLDA) after mitral transcatheter valve edge‐to‐edge repair (M‐TEER) has been reported in up to 5% of patients. However, complete embolization of the M‐TEER device is exceedingly rare. Device retrievals in all previously reported cases were completed by vascular surgery cut down at the end. In this case, we are
Aalaei-Andabili SH +2 more
europepmc +2 more sources
Complications Following MitraClip Implantation [PDF]
Current Cardiology Reports, 2021 Abstract Purpose of Review To provide a detailed overview of complications associated with MitraClip therapy and its development over time with the aim to alert physicians for early recognition of complications and to offer treatment strategies for each complication, if possible.
Katharina Schnitzler +5 more
openaire +3 more sources
Successful Mitral Valve Repair for Single Leaflet Device Attachment Following Transcatheter Edge-to-Edge Repair: A Case Report. [PDF]
Case Rep CardiolAn 87‐year‐old man underwent transcatheter edge‐to‐edge repair (TEER), one MitraClip NT︎ from anterior commissure (AC), 8 months prior for severe mitral regurgitation (MR) due to functional etiology and A1 chordal rupture, complicated by heart failure.
Makiura T, Daimon M, Katsumata T.
europepmc +2 more sources
A Case of Venous Tissue Dissection During Transcatheter MitraClip Surgery. [PDF]
Catheter Cardiovasc IntervABSTRACT The MitraClip system has been widely used to treat mitral regurgitation. The complications associated with MitraClip surgery typically include clip detachment and mitral valve injury. However, cases of venous tissue dissection during surgery are relatively rare.
Ouyang S +5 more
europepmc +2 more sources
Review of the MitraClip clinical evidence.
Minerva cardioangiologica, 2012 MitraClip system is the only catheter-based device for percutaneous mitral valve repair available for clinical use, after receipt of the CE Mark in 2008, while it is currently under review for FDA approval in the US. To date, over 3500 MitraClip implants have been performed worldwide, mainly in high risk surgical patients.
Maisano F +6 more
openaire +3 more sources